This is a demo store. No orders will be fulfilled.
In stock
SAR121.50
(Inclusive of VAT)
Overview
USED FOR PRIMARY HYPERCHOLESTEROLAEMIA AND COMBINED (MIXED) HYPERLIPIDAEMIA, HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA, HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE
LIPIGARD IS INDICATED AS AN ADJUNCT TO DIET FOR REDUCTION OF ELEVATED TOTAL CHOLESTEROL (TOTAL-C), LDL-CHOLESTEROL (LDL-C), APOLIPOPROTEIN B, AND TRIGLYCERIDES IN ADULTS, ADOLESCENTS AND CHILDREN AGED 10 YEARS OR OLDER WITH PRIMARY HYPERCHOLESTEROLAEMIA INCLUDING FAMILIAL HYPERCHOLESTEROLAEMIA (HETEROZYGOUS VARIANT) OR COMBINED (MIXED) HYPERLIPIDAEMIA (CORRESPONDING TO TYPES IIA AND IIB OF THE FREDRICKSON CLASSIFICATION) WHEN RESPONSE TO DIET AND OTHER NONPHARMACOLOGICAL MEASURES IS INADEQUATE.
LIPIGARD IS ALSO INDICATED TO REDUCE TOTAL-C AND LDL-C IN ADULTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA AS AN ADJUNCT TO OTHER LIPID-LOWERING TREATMENTS (E.G. LDL APHERESIS) OR IF SUCH TREATMENTS ARE UNAVAILABLE.
PREVENTION OF CARDIOVASCULAR EVENTS IN ADULT PATIENTS ESTIMATED TO HAVE A HIGH RISK FOR A FIRST CARDIOVASCULAR EVENT , AS AN ADJUNCT TO CORRECTION OF OTHER RISK FACTORS.
| instructions | Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure. |
|---|---|
| Treatment For | Used for Primary hypercholesterolaemia and combined (mixed) hyperlipidaemia, Heterozygous familial hypercholesterolaemia, Homozygous familial hypercholesterolaemia and Prevention of cardiovascular disease |
| Form | TABLET |
| Manufacturer | GULF PHARMACEIUTICAL INDUSTRIES R.A.K |
| Promotion Discount | Yes |
Write Your Own Review
